Cat. No. | Product name | CAS No. |
DC11923 |
BMS-986120
Featured
BMS-986120 (BMS986120) is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4. |
1478712-37-6 |
DCAPI1140 |
Bumetanide
Featured
Bumetanide |
28395-03-1 |
DC9185 |
Candesartan cilexetil
Featured
Candesartan Cilexetil (TCV-116) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. |
145040-37-5 |
DC9142 |
Candesartan
Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM. |
139481-59-7 |
DC7005 |
Cangrelor free acid
Featured
Cangrelor is a P2Y12 inhibitor, and was approved in June 2015 as an antiplatelet drug for intravenous application. Cangrelor is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggrega |
163706-06-7 |
DC7990 |
Cariporide
Cariporide is a selective Na+/H+ exchanger isoform 1 (NHE1) inhibitor (IC50 values are 0.05, 3 and 1000 μM for NHE1, NHE3 and NHE2 respectively). |
159138-80-4 |
DC8471 |
CGS 21680 hydrochloride
Featured
CGS 21680 hydrochloride is an A2A adenosine receptor agonist (Ki = 27 nM). |
124431-80-7 |
DC9160 |
Cilnidipine
Featured
Cilnidipine(FRC8653) is a dual L- and N-type calcium channel blocker and displays antihypertensive, sympatholytic and neuroprotective activity. |
132203-70-4 |
DC9174 |
Cinepazide maleate
Cinepazide Maleate is a vasodilator. |
26328-04-1 |
DC11098 |
CKD-519
CKD-519 (Rocacetrapib, CKD519) is a potent, selective cholesteryl ester transfer protein (CETP) inhibitor, inhibits the CETP-mediated transfer of cholesteryl ester in human serum with IC50 of 2.3 nM. |
1402796-27-3 |
DC9380 |
Cleviprex
Featured
Clevidipine(Clevidipine) is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension. |
167221-71-8 |
DC3147 |
Clopidogrel hydrogensulfate
Clopidogrel (Plavix) is an oral, thienopyridine class antiplatelet agent. |
120202-66-6 |
DCAPI1417 |
Clopidogrel
Clopidogrel is an irreversible inhibitor of the P2Y12 receptor, which is responsible for initiating signal transduction via a GPCR. The signal cascade initiates platelet aggregation and thus clopidogrel has the effect of “thinning” the blood. |
113665-84-2 |
DC8913 |
Dabigatran etexilate mesylate
Featured
Dabigatran etexilate mesylate (BIBR 1048MS) is the orally active prodrug of dabigatran. Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM. |
872728-81-9 |
DC7397 |
Darapladib
Featured
Darapladib is a selective and orally active inhibitor of Lp-PLA2 (IC50= 270 pM) |
356057-34-6 |
DCAPI1152 |
Diltiazem HCl (Tiazac)
Diltiazem HCl (Tiazac) |
33286-22-5 |
DC10446 |
(3R,4S,5S)-tert-butyl 3-Methoxy-5-Methyl-4-(MethylaMino)heptanoate hydroc hloride
Featured
Diltiazem hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). |
120205-48-3 |
DCAPI1457 |
Dronedarone Hydrochloride
Dronedarone is a Class III antiarrhythmic and a multi-channel blocker for atrial fibrillation. It blocks potassium and sodium and is a calcium channel protein inhibitor. |
141625-93-6 |
DC9595 |
E-4031
E-4031 is a benzenesulfonamide antiarrhythmic agent; blocks the ATP-sensitive potassium channel. |
113559-13-0 |
DC8533 |
E5555 hydrobromide
E5555 shows potent inhibitory effects on human platelet aggregation induced by thrombin and TRAP with IC values of 0.064 and 0.031 μM respectively. |
474550-69-1 |
DC8305 |
Edoxaban
Featured
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention |
480449-71-6 |
DC8793 |
Edoxaban tosylate monohydrate
Featured
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention |
1229194-11-9 |